Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Tazeen Ahmad is an analyst at B of A Securities. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/15/2025
Buy Now | Get Alert | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
06/09/2025 | ASND | Buy Now | Ascendis Pharma | $170.80 | 26.46% | Tazeen Ahmad56% | $201 → $216 | Maintains | Buy | Get Alert |
06/05/2025 | ACAD | Buy Now | ACADIA Pharmaceuticals | $21.71 | 5.94% | Tazeen Ahmad56% | $18 → $23 | Maintains | Neutral | Get Alert |
06/03/2025 | ASND | Buy Now | Ascendis Pharma | $170.80 | 17.68% | Tazeen Ahmad56% | $196 → $201 | Maintains | Buy | Get Alert |
05/28/2025 | PRTA | Buy Now | Prothena Corp | $5.00 | -20% | Tazeen Ahmad56% | $22 → $4 | Downgrade | Neutral → Underperform | Get Alert |
05/19/2025 | STRO | Buy Now | Sutro Biopharma | $0.80 | 0.11% | Tazeen Ahmad56% | $1 → $0.8 | Maintains | Underperform | Get Alert |
05/19/2025 | DNLI | Buy Now | Denali Therapeutics | $14.55 | 85.57% | Tazeen Ahmad56% | $28 → $27 | Maintains | Buy | Get Alert |
05/09/2025 | APLS | Buy Now | Apellis Pharmaceuticals | $18.83 | 22.15% | Tazeen Ahmad56% | $41 → $23 | Downgrade | Buy → Neutral | Get Alert |
05/09/2025 | PTCT | Buy Now | PTC Therapeutics | $51.26 | 32.66% | Tazeen Ahmad56% | $55 → $68 | Upgrade | Neutral → Buy | Get Alert |
04/10/2025 | RYTM | Buy Now | Rhythm Pharmaceuticals | $62.90 | 8.11% | Tazeen Ahmad56% | $63 → $68 | Maintains | Buy | Get Alert |
03/21/2025 | ALNY | Buy Now | Alnylam Pharmaceuticals | $306.97 | 5.87% | Tazeen Ahmad56% | $302 → $325 | Maintains | Buy | Get Alert |
03/14/2025 | STRO | Buy Now | Sutro Biopharma | $0.80 | 25.14% | Tazeen Ahmad56% | $11 → $1 | Downgrade | Buy → Underperform | Get Alert |
03/12/2025 | ARVN | Buy Now | Arvinas | $7.39 | 278.89% | Tazeen Ahmad56% | $54 → $28 | Maintains | Buy | Get Alert |
03/11/2025 | PTCT | Buy Now | PTC Therapeutics | $51.26 | 7.3% | Tazeen Ahmad56% | $41 → $55 | Upgrade | Underperform → Neutral | Get Alert |
03/10/2025 | MRUS | Buy Now | Merus | $54.61 | 28.18% | Tazeen Ahmad56% | $73 → $70 | Maintains | Buy | Get Alert |
03/10/2025 | FDMT | Buy Now | 4D Molecular Therapeutics | $4.39 | 811.16% | Tazeen Ahmad56% | $42 → $40 | Maintains | Buy | Get Alert |
03/10/2025 | DNLI | Buy Now | Denali Therapeutics | $14.55 | 92.44% | Tazeen Ahmad56% | $30 → $28 | Maintains | Buy | Get Alert |
02/07/2025 | NBIX | Buy Now | Neurocrine Biosciences | $124.39 | 43.9% | Tazeen Ahmad56% | $184 → $179 | Maintains | Buy | Get Alert |
12/19/2024 | PRTA | Buy Now | Prothena Corp | $5.00 | 340% | Tazeen Ahmad56% | $26 → $22 | Maintains | Neutral | Get Alert |
12/18/2024 | FDMT | Buy Now | 4D Molecular Therapeutics | $4.39 | 947.84% | Tazeen Ahmad56% | $79 → $46 | Maintains | Buy | Get Alert |
12/18/2024 | KALV | Buy Now | KalVista Pharma | $13.00 | 69.23% | Tazeen Ahmad56% | → $22 | Initiates | → Buy | Get Alert |
12/16/2024 | PEPG | Buy Now | PepGen | $1.43 | 109.79% | Tazeen Ahmad56% | $6 → $3 | Downgrade | Neutral → Underperform | Get Alert |
11/18/2024 | PEPG | Buy Now | PepGen | $1.43 | 319.58% | Tazeen Ahmad56% | $10 → $6 | Maintains | Neutral | Get Alert |
11/06/2024 | APLS | Buy Now | Apellis Pharmaceuticals | $18.83 | 149.6% | Tazeen Ahmad56% | $61 → $47 | Maintains | Buy | Get Alert |
10/30/2024 | INCY | Buy Now | Incyte | $67.75 | 32.84% | Tazeen Ahmad56% | $68 → $90 | Upgrade | Neutral → Buy | Get Alert |
10/17/2024 | FOLD | Buy Now | Amicus Therapeutics | $6.03 | 148.76% | Tazeen Ahmad56% | $13 → $15 | Maintains | Buy | Get Alert |
10/14/2024 | ALNY | Buy Now | Alnylam Pharmaceuticals | $306.97 | 2.29% | Tazeen Ahmad56% | $307 → $314 | Maintains | Buy | Get Alert |
10/14/2024 | RYTM | Buy Now | Rhythm Pharmaceuticals | $62.90 | -17.33% | Tazeen Ahmad56% | $48 → $52 | Maintains | Neutral | Get Alert |
10/09/2024 | SAGE | Buy Now | Sage Therapeutics | $6.90 | -13.04% | Tazeen Ahmad56% | $11 → $6 | Maintains | Underperform | Get Alert |
10/01/2024 | PRTA | Buy Now | Prothena Corp | $5.00 | 520% | Tazeen Ahmad56% | $33 → $31 | Maintains | Neutral | Get Alert |
09/23/2024 | ASND | Buy Now | Ascendis Pharma | $170.80 | 11.83% | Tazeen Ahmad56% | $175 → $191 | Maintains | Buy | Get Alert |
09/16/2024 | INCY | Buy Now | Incyte | $67.75 | 0.37% | Tazeen Ahmad56% | $66 → $68 | Maintains | Neutral | Get Alert |
09/16/2024 | BNTX | Buy Now | BioNTech | $106.57 | 40.75% | Tazeen Ahmad56% | $125 → $150 | Maintains | Buy | Get Alert |
09/12/2024 | FULC | Buy Now | Fulcrum Therapeutics | $6.85 | -70.8% | Tazeen Ahmad56% | $10 → $2 | Downgrade | Neutral → Underperform | Get Alert |
09/09/2024 | FULC | Buy Now | Fulcrum Therapeutics | $6.85 | 45.99% | Tazeen Ahmad56% | $5 → $10 | Upgrade | Underperform → Neutral | Get Alert |
09/04/2024 | ASND | Buy Now | Ascendis Pharma | $170.80 | 2.46% | Tazeen Ahmad56% | $165 → $175 | Maintains | Buy | Get Alert |
09/04/2024 | ALNY | Buy Now | Alnylam Pharmaceuticals | $306.97 | 0.01% | Tazeen Ahmad56% | $295 → $307 | Maintains | Buy | Get Alert |
09/04/2024 | DNLI | Buy Now | Denali Therapeutics | $14.55 | 99.31% | Tazeen Ahmad56% | $25 → $29 | Maintains | Buy | Get Alert |
07/31/2024 | INCY | Buy Now | Incyte | $67.75 | -2.58% | Tazeen Ahmad56% | $62 → $66 | Maintains | Neutral | Get Alert |
06/25/2024 | MRUS | Buy Now | Merus | $54.61 | 39.17% | Tazeen Ahmad56% | $76 → $76 | Maintains | Buy | Get Alert |
06/24/2024 | ARGX | Buy Now | argenx | $577.89 | 5.04% | Tazeen Ahmad56% | $535 → $607 | Reiterates | Buy → Buy | Get Alert |
06/21/2024 | PTCT | Buy Now | PTC Therapeutics | $51.26 | -37.57% | Tazeen Ahmad56% | $25 → $32 | Maintains | Underperform | Get Alert |
06/21/2024 | SRPT | Buy Now | Sarepta Therapeutics | $36.36 | 485.81% | Tazeen Ahmad56% | $166 → $213 | Maintains | Buy | Get Alert |
06/05/2024 | MRUS | Buy Now | Merus | $54.61 | 39.17% | Tazeen Ahmad56% | $80 → $76 | Maintains | Buy | Get Alert |
05/31/2024 | RARE | Buy Now | Ultragenyx Pharmaceutical | $37.49 | 102.72% | Tazeen Ahmad56% | $83 → $76 | Maintains | Buy | Get Alert |
05/29/2024 | MRUS | Buy Now | Merus | $54.61 | 46.49% | Tazeen Ahmad56% | $61 → $80 | Maintains | Buy | Get Alert |
05/24/2024 | MRUS | Buy Now | Merus | $54.61 | 11.7% | Tazeen Ahmad56% | $52 → $61 | Maintains | Buy | Get Alert |
05/10/2024 | ACAD | Buy Now | ACADIA Pharmaceuticals | $21.71 | 1.34% | Tazeen Ahmad56% | $26 → $22 | Maintains | Neutral | Get Alert |
05/10/2024 | FOLD | Buy Now | Amicus Therapeutics | $6.03 | 115.59% | Tazeen Ahmad56% | $14 → $13 | Maintains | Buy | Get Alert |
05/08/2024 | RYTM | Buy Now | Rhythm Pharmaceuticals | $62.90 | -33.23% | Tazeen Ahmad56% | $49 → $42 | Downgrade | Buy → Neutral | Get Alert |
05/08/2024 | STRO | Buy Now | Sutro Biopharma | $0.80 | 1401.69% | Tazeen Ahmad56% | → $12 | Initiates | → Buy | Get Alert |
04/17/2024 | SAGE | Buy Now | Sage Therapeutics | $6.90 | 102.9% | Tazeen Ahmad56% | $24 → $14 | Downgrade | Neutral → Underperform | Get Alert |
04/12/2024 | FOLD | Buy Now | Amicus Therapeutics | $6.03 | 132.17% | Tazeen Ahmad56% | $16 → $14 | Maintains | Buy | Get Alert |
04/09/2024 | INZY | Buy Now | Inozyme Pharma | $3.98 | 251.76% | Tazeen Ahmad56% | $16 → $14 | Maintains | Buy | Get Alert |
03/28/2024 | ANNX | Buy Now | Annexon | $2.64 | 278.79% | Tazeen Ahmad56% | $7 → $10 | Maintains | Buy | Get Alert |
03/28/2024 | FATE | Buy Now | Fate Therapeutics | $1.26 | 376.19% | Tazeen Ahmad56% | $2 → $6 | Maintains | Underperform | Get Alert |
03/13/2024 | INCY | Buy Now | Incyte | $67.75 | -1.11% | Tazeen Ahmad56% | $69 → $67 | Maintains | Neutral | Get Alert |
03/12/2024 | ACAD | Buy Now | ACADIA Pharmaceuticals | $21.71 | 38.19% | Tazeen Ahmad56% | $33 → $30 | Maintains | Neutral | Get Alert |
02/09/2024 | OCUL | Buy Now | Ocular Therapeutix | $8.73 | 71.82% | Tazeen Ahmad56% | → $15 | Initiates | → Buy | Get Alert |
01/30/2024 | PRTA | Buy Now | Prothena Corp | $5.00 | 660% | Tazeen Ahmad56% | $68 → $38 | Downgrade | Buy → Neutral | Get Alert |
01/05/2024 | CYT | Buy Now | Cyteir Therapeutics | — | — | Tazeen Ahmad56% | → $3 | Downgrade | Neutral → Underperform | Get Alert |
12/21/2023 | ANNX | Buy Now | Annexon | $2.64 | 127.27% | Tazeen Ahmad56% | $4 → $6 | Upgrade | Neutral → Buy | Get Alert |
12/14/2023 | ACHL | Buy Now | Achilles Therapeutics | — | — | Tazeen Ahmad56% | $7 → $0.5 | Downgrade | Buy → Underperform | Get Alert |
12/07/2023 | PHVS | Buy Now | Pharvaris | $18.81 | -41.52% | Tazeen Ahmad56% | $8 → $11 | Maintains | Underperform | Get Alert |
12/05/2023 | APLS | Buy Now | Apellis Pharmaceuticals | $18.83 | 351.41% | Tazeen Ahmad56% | $52 → $85 | Upgrade | Neutral → Buy | Get Alert |
10/12/2023 | APLS | Buy Now | Apellis Pharmaceuticals | $18.83 | 144.29% | Tazeen Ahmad56% | $44 → $46 | Maintains | Neutral | Get Alert |
09/19/2023 | PTCT | Buy Now | PTC Therapeutics | $51.26 | -55.13% | Tazeen Ahmad56% | $43 → $23 | Maintains | Underperform | Get Alert |
09/08/2023 | APLS | Buy Now | Apellis Pharmaceuticals | $18.83 | 128.36% | Tazeen Ahmad56% | $40 → $43 | Maintains | Neutral | Get Alert |
09/08/2023 | SAGE | Buy Now | Sage Therapeutics | $6.90 | 247.83% | Tazeen Ahmad56% | $25 → $24 | Maintains | Neutral | Get Alert |
08/03/2023 | CERE | Buy Now | Cerevel Therapeutics Hldg | — | — | Tazeen Ahmad56% | $36 → $31 | Downgrade | Buy → Neutral | Get Alert |
08/02/2023 | RYTM | Buy Now | Rhythm Pharmaceuticals | $62.90 | -57.07% | Tazeen Ahmad56% | $22 → $27 | Upgrade | Neutral → Buy | Get Alert |
08/01/2023 | APLS | Buy Now | Apellis Pharmaceuticals | $18.83 | 112.43% | Tazeen Ahmad56% | $114 → $40 | Downgrade | Buy → Neutral | Get Alert |
07/13/2023 | BCRX | Buy Now | BioCryst Pharma | $10.25 | -2.44% | Tazeen Ahmad56% | → $10 | Upgrade | Neutral → Buy | Get Alert |
06/08/2023 | FDMT | Buy Now | 4D Molecular Therapeutics | $4.39 | 651.71% | Tazeen Ahmad56% | $28 → $33 | Maintains | Buy | Get Alert |
05/26/2023 | ANNX | Buy Now | Annexon | $2.64 | 13.64% | Tazeen Ahmad56% | $8 → $3 | Downgrade | Buy → Neutral | Get Alert |
05/24/2023 | PTCT | Buy Now | PTC Therapeutics | $51.26 | -18.06% | Tazeen Ahmad56% | → $42 | Maintains | Underperform | Get Alert |
05/23/2023 | SAGE | Buy Now | Sage Therapeutics | $6.90 | 784.07% | Tazeen Ahmad56% | $56 → $61 | Maintains | Buy | Get Alert |
05/22/2023 | ACAD | Buy Now | ACADIA Pharmaceuticals | $21.71 | 19.76% | Tazeen Ahmad56% | $23 → $26 | Maintains | Neutral | Get Alert |
05/18/2023 | PTCT | Buy Now | PTC Therapeutics | $51.26 | -16.11% | Tazeen Ahmad56% | $36 → $43 | Maintains | Underperform | Get Alert |
05/15/2023 | SRPT | Buy Now | Sarepta Therapeutics | $36.36 | 384.05% | Tazeen Ahmad56% | $164 → $176 | Maintains | Buy | Get Alert |
05/10/2023 | SRPT | Buy Now | Sarepta Therapeutics | $36.36 | 351.05% | Tazeen Ahmad56% | $164 → $164 | Maintains | Buy | Get Alert |
05/04/2023 | INCY | Buy Now | Incyte | $67.75 | 23.99% | Tazeen Ahmad56% | $93 → $84 | Downgrade | Buy → Neutral | Get Alert |
05/03/2023 | SAGE | Buy Now | Sage Therapeutics | $6.90 | 711.61% | Tazeen Ahmad56% | $55 → $56 | Maintains | Buy | Get Alert |
04/24/2023 | FOLD | Buy Now | Amicus Therapeutics | $6.03 | 165.34% | Tazeen Ahmad56% | $17 → $16 | Maintains | Buy | Get Alert |
04/24/2023 | ADCT | Buy Now | ADC Therapeutics | $3.70 | -45.95% | Tazeen Ahmad56% | $7 → $2 | Downgrade | Neutral → Underperform | Get Alert |
04/14/2023 | SRPT | Buy Now | Sarepta Therapeutics | $36.36 | 351.05% | Tazeen Ahmad56% | $164 → $164 | Maintains | Buy | Get Alert |
04/04/2023 | ASND | Buy Now | Ascendis Pharma | $170.80 | -46.14% | Tazeen Ahmad56% | $132 → $92 | Maintains | Buy | Get Alert |
03/28/2023 | BNTX | Buy Now | BioNTech | $106.57 | 82.04% | Tazeen Ahmad56% | $239 → $194 | Maintains | Buy | Get Alert |
03/28/2023 | FOLD | Buy Now | Amicus Therapeutics | $6.03 | 181.92% | Tazeen Ahmad56% | $16 → $17 | Maintains | Buy | Get Alert |
03/20/2023 | SRPT | Buy Now | Sarepta Therapeutics | $36.36 | 351.05% | Tazeen Ahmad56% | $164 → $164 | Maintains | Buy | Get Alert |
03/17/2023 | SRPT | Buy Now | Sarepta Therapeutics | $36.36 | 351.05% | Tazeen Ahmad56% | → $164 | Maintains | Buy | Get Alert |
03/14/2023 | ACAD | Buy Now | ACADIA Pharmaceuticals | $21.71 | 5.94% | Tazeen Ahmad56% | → $23 | Maintains | Neutral | Get Alert |
02/28/2023 | SRPT | Buy Now | Sarepta Therapeutics | $36.36 | 340.04% | Tazeen Ahmad56% | → $160 | Maintains | Buy | Get Alert |
02/22/2023 | PTCT | Buy Now | PTC Therapeutics | $51.26 | -29.77% | Tazeen Ahmad56% | → $36 | Maintains | Underperform | Get Alert |
02/16/2023 | GRTX | Buy Now | Galera Therapeutics | $0.02 | 29561.02% | Tazeen Ahmad56% | $2 → $7 | Upgrade | Underperform → Buy | Get Alert |
02/06/2023 | SAGE | Buy Now | Sage Therapeutics | $6.90 | 697.11% | Tazeen Ahmad56% | → $55 | Maintains | Buy | Get Alert |
01/30/2023 | CYT | Buy Now | Cyteir Therapeutics | — | — | Tazeen Ahmad56% | $4 → $2 | Downgrade | Buy → Neutral | Get Alert |
01/06/2023 | FATE | Buy Now | Fate Therapeutics | $1.26 | 217.46% | Tazeen Ahmad56% | $72 → $4 | Downgrade | Buy → Underperform | Get Alert |
12/15/2022 | BNTX | Buy Now | BioNTech | $106.57 | 124.27% | Tazeen Ahmad56% | → $239 | Upgrade | Neutral → Buy | Get Alert |
12/01/2022 | SQZ | Buy Now | SQZ Biotechnologies | — | — | Tazeen Ahmad56% | $9 → $2 | Downgrade | Buy → Underperform | Get Alert |
11/29/2022 | SRPT | Buy Now | Sarepta Therapeutics | $36.36 | 279.54% | Tazeen Ahmad56% | $129 → $138 | Maintains | Buy | Get Alert |
11/21/2022 | PRLD | Buy Now | Prelude Therapeutics | $1.09 | 450.46% | Tazeen Ahmad56% | → $6 | Downgrade | Neutral → Underperform | Get Alert |
11/17/2022 | SRZN | Buy Now | Surrozen | $8.12 | -87.68% | Tazeen Ahmad56% | $5 → $1 | Downgrade | Neutral → Underperform | Get Alert |
11/09/2022 | ADCT | Buy Now | ADC Therapeutics | $3.70 | 89.19% | Tazeen Ahmad56% | $14 → $7 | Downgrade | Buy → Neutral | Get Alert |
11/03/2022 | SRPT | Buy Now | Sarepta Therapeutics | $36.36 | 254.79% | Tazeen Ahmad56% | $130 → $129 | Maintains | Buy | Get Alert |
10/20/2022 | CERE | Buy Now | Cerevel Therapeutics Hldg | — | — | Tazeen Ahmad56% | → $39 | Initiates | → Buy | Get Alert |
09/28/2022 | PRTA | Buy Now | Prothena Corp | $5.00 | — | Tazeen Ahmad56% | — | Upgrade | Neutral → Buy | Get Alert |
08/22/2022 | PHVS | Buy Now | Pharvaris | $18.81 | -30.89% | Tazeen Ahmad56% | $26 → $13 | Downgrade | Neutral → Underperform | Get Alert |
08/18/2022 | SRPT | Buy Now | Sarepta Therapeutics | $36.36 | 241.03% | Tazeen Ahmad56% | $104 → $124 | Maintains | Buy | Get Alert |
08/05/2022 | RYTM | Buy Now | Rhythm Pharmaceuticals | $62.90 | -68.2% | Tazeen Ahmad56% | $8 → $20 | Upgrade | Underperform → Neutral | Get Alert |
06/07/2022 | PRAX | Buy Now | Praxis Precision Medicine | $44.30 | -90.97% | Tazeen Ahmad56% | $26 → $4 | Downgrade | Buy → Neutral | Get Alert |
05/31/2022 | PEPG | Buy Now | PepGen | $1.43 | 1018.88% | Tazeen Ahmad56% | → $16 | Initiates | → Buy | Get Alert |
05/27/2022 | SRZN | Buy Now | Surrozen | $8.12 | -38.42% | Tazeen Ahmad56% | → $5 | Downgrade | Buy → Neutral | Get Alert |
05/27/2022 | MTEM | Buy Now | Molecular Templates | $0.00 | 499900% | Tazeen Ahmad56% | → $1.5 | Downgrade | Buy → Underperform | Get Alert |
05/27/2022 | GRTX | Buy Now | Galera Therapeutics | $0.02 | 8374.58% | Tazeen Ahmad56% | → $2 | Downgrade | Neutral → Underperform | Get Alert |
04/19/2022 | SRPT | Buy Now | Sarepta Therapeutics | $36.36 | 194.28% | Tazeen Ahmad56% | $105 → $107 | Maintains | Buy | Get Alert |
04/19/2022 | PTCT | Buy Now | PTC Therapeutics | $51.26 | -35.62% | Tazeen Ahmad56% | $34 → $33 | Maintains | Underperform | Get Alert |
04/11/2022 | BCRX | Buy Now | BioCryst Pharma | $10.25 | 36.59% | Tazeen Ahmad56% | → $14 | Downgrade | Buy → Neutral | Get Alert |
03/15/2022 | ASND | Buy Now | Ascendis Pharma | $170.80 | -5.74% | Tazeen Ahmad56% | $148 → $161 | Upgrade | Neutral → Buy | Get Alert |
03/15/2022 | PRLD | Buy Now | Prelude Therapeutics | $1.09 | 817.43% | Tazeen Ahmad56% | $50 → $10 | Downgrade | Buy → Neutral | Get Alert |
03/03/2022 | SRPT | Buy Now | Sarepta Therapeutics | $36.36 | 188.78% | Tazeen Ahmad56% | $105 → $105 | Maintains | Buy | Get Alert |
03/01/2022 | ACAD | Buy Now | ACADIA Pharmaceuticals | $21.71 | 42.79% | Tazeen Ahmad56% | $32 → $31 | Maintains | Neutral | Get Alert |
02/25/2022 | SAGE | Buy Now | Sage Therapeutics | $6.90 | 610.16% | Tazeen Ahmad56% | $50 → $49 | Maintains | Buy | Get Alert |
01/26/2022 | SRPT | Buy Now | Sarepta Therapeutics | $36.36 | 188.78% | Tazeen Ahmad56% | $122 → $105 | Maintains | Buy | Get Alert |
01/13/2022 | SRPT | Buy Now | Sarepta Therapeutics | $36.36 | 235.53% | Tazeen Ahmad56% | $122 → $122 | Maintains | Buy | Get Alert |
01/12/2022 | SAGE | Buy Now | Sage Therapeutics | $6.90 | 769.58% | Tazeen Ahmad56% | → $60 | Maintains | Buy | Get Alert |
12/21/2021 | ACAD | Buy Now | ACADIA Pharmaceuticals | $21.71 | 47.4% | Tazeen Ahmad56% | $28 → $32 | Maintains | Neutral | Get Alert |
11/02/2021 | PYXS | Buy Now | Pyxis Oncology | $1.20 | 1233.33% | Tazeen Ahmad56% | → $16 | Initiates | → Neutral | Get Alert |
10/27/2021 | CRTX | Buy Now | Cortexyme | — | — | Tazeen Ahmad56% | — | Downgrade | Neutral → Underperform | Get Alert |
10/20/2021 | ASND | Buy Now | Ascendis Pharma | $170.80 | -1.05% | Tazeen Ahmad56% | $164 → $169 | Downgrade | Buy → Neutral | Get Alert |
10/18/2021 | PTCT | Buy Now | PTC Therapeutics | $51.26 | -25.87% | Tazeen Ahmad56% | → $38 | Downgrade | Neutral → Underperform | Get Alert |
10/11/2021 | SRZN | Buy Now | Surrozen | $8.12 | 35.47% | Tazeen Ahmad56% | → $11 | Initiates | → Buy | Get Alert |
09/09/2021 | ARVN | Buy Now | Arvinas | $7.39 | 1388.5% | Tazeen Ahmad56% | → $110 | Initiates | → Buy | Get Alert |
08/26/2021 | PRAX | Buy Now | Praxis Precision Medicine | $44.30 | -36.79% | Tazeen Ahmad56% | → $28 | Initiates | → Buy | Get Alert |
08/05/2021 | SRPT | Buy Now | Sarepta Therapeutics | $36.36 | 235.53% | Tazeen Ahmad56% | $135 → $122 | Maintains | Buy | Get Alert |
08/05/2021 | ACAD | Buy Now | ACADIA Pharmaceuticals | $21.71 | 15.15% | Tazeen Ahmad56% | $26 → $25 | Maintains | Neutral | Get Alert |
08/04/2021 | SAGE | Buy Now | Sage Therapeutics | $6.90 | 813.06% | Tazeen Ahmad56% | $74 → $63 | Maintains | Buy | Get Alert |
08/04/2021 | RYTM | Buy Now | Rhythm Pharmaceuticals | $62.90 | -72.97% | Tazeen Ahmad56% | $33 → $17 | Downgrade | Neutral → Underperform | Get Alert |
07/27/2021 | PRLD | Buy Now | Prelude Therapeutics | $1.09 | 5404.59% | Tazeen Ahmad56% | → $60 | Upgrade | Neutral → Buy | Get Alert |
07/21/2021 | ACAD | Buy Now | ACADIA Pharmaceuticals | $21.71 | 19.76% | Tazeen Ahmad56% | $24 → $26 | Maintains | Neutral | Get Alert |
06/29/2021 | RARE | Buy Now | Ultragenyx Pharmaceutical | $37.49 | 332.12% | Tazeen Ahmad56% | → $162 | Upgrade | Neutral → Buy | Get Alert |
06/18/2021 | PRTA | Buy Now | Prothena Corp | $5.00 | 880% | Tazeen Ahmad56% | → $49 | Upgrade | Underperform → Neutral | Get Alert |
06/16/2021 | SAGE | Buy Now | Sage Therapeutics | $6.90 | 972.48% | Tazeen Ahmad56% | $97 → $74 | Maintains | Buy | Get Alert |
04/21/2021 | MTEM | Buy Now | Molecular Templates | $0.00 | 3999900% | Tazeen Ahmad56% | → $12 | Initiates | → Buy | Get Alert |
03/30/2021 | AKUS | Buy Now | Akouos | — | — | Tazeen Ahmad56% | $24 → $20 | Downgrade | Buy → Neutral | Get Alert |
03/30/2021 | ORPH | Buy Now | Orphazyme | — | — | Tazeen Ahmad56% | $13 → $5 | Downgrade | Neutral → Underperform | Get Alert |
03/10/2021 | ACAD | Buy Now | ACADIA Pharmaceuticals | $21.71 | — | Tazeen Ahmad56% | — | Downgrade | Buy → Neutral | Get Alert |
03/02/2021 | PHVS | Buy Now | Pharvaris | $18.81 | 117.97% | Tazeen Ahmad56% | → $41 | Initiates | → Neutral | Get Alert |
02/26/2021 | SRPT | Buy Now | Sarepta Therapeutics | $36.36 | 271.29% | Tazeen Ahmad56% | $135 → $135 | Maintains | Buy | Get Alert |
02/12/2021 | PTCT | Buy Now | PTC Therapeutics | $51.26 | 32.66% | Tazeen Ahmad56% | $58 → $68 | Downgrade | Buy → Neutral | Get Alert |
01/08/2021 | SRPT | Buy Now | Sarepta Therapeutics | $36.36 | 271.29% | Tazeen Ahmad56% | → $135 | Maintains | Buy | Get Alert |
01/05/2021 | FDMT | Buy Now | 4D Molecular Therapeutics | $4.39 | 970.62% | Tazeen Ahmad56% | → $47 | Initiates | → Buy | Get Alert |
12/18/2020 | SRPT | Buy Now | Sarepta Therapeutics | $36.36 | 433.55% | Tazeen Ahmad56% | → $194 | Maintains | Buy | Get Alert |
12/07/2020 | CRTX | Buy Now | Cortexyme | — | — | Tazeen Ahmad56% | — | Upgrade | Neutral → Buy | Get Alert |
12/01/2020 | SAGE | Buy Now | Sage Therapeutics | $6.90 | 1102.92% | Tazeen Ahmad56% | $95 → $83 | Maintains | Buy | Get Alert |
12/01/2020 | BNTX | Buy Now | BioNTech | $106.57 | — | Tazeen Ahmad56% | — | Downgrade | Buy → Neutral | Get Alert |
11/30/2020 | RYTM | Buy Now | Rhythm Pharmaceuticals | $62.90 | -47.54% | Tazeen Ahmad56% | $27 → $33 | Downgrade | Buy → Neutral | Get Alert |
11/24/2020 | SQZ | Buy Now | SQZ Biotechnologies | — | — | Tazeen Ahmad56% | → $37 | Initiates | → Buy | Get Alert |
11/16/2020 | SRPT | Buy Now | Sarepta Therapeutics | $36.36 | 403.3% | Tazeen Ahmad56% | → $183 | Maintains | Buy | Get Alert |
11/16/2020 | SAGE | Buy Now | Sage Therapeutics | $6.90 | 1276.83% | Tazeen Ahmad56% | $72 → $95 | Maintains | Buy | Get Alert |
10/20/2020 | PRLD | Buy Now | Prelude Therapeutics | $1.09 | 3569.72% | Tazeen Ahmad56% | → $40 | Initiates | → Buy | Get Alert |
10/15/2020 | RARE | Buy Now | Ultragenyx Pharmaceutical | $37.49 | 185.41% | Tazeen Ahmad56% | $93 → $107 | Maintains | Buy | Get Alert |
10/06/2020 | ARGX | Buy Now | argenx | $577.89 | -48.43% | Tazeen Ahmad56% | $265 → $298 | Maintains | Buy | Get Alert |
09/25/2020 | ETNB | Buy Now | 89bio | $10.40 | 313.46% | Tazeen Ahmad56% | → $43 | Upgrade | Neutral → Buy | Get Alert |
09/14/2020 | SAGE | Buy Now | Sage Therapeutics | $6.90 | 885.52% | Tazeen Ahmad56% | $66 → $68 | Maintains | Buy | Get Alert |
08/18/2020 | ANNX | Buy Now | Annexon | $2.64 | 1150% | Tazeen Ahmad56% | → $33 | Initiates | → Buy | Get Alert |
08/18/2020 | INZY | Buy Now | Inozyme Pharma | $3.98 | 729.15% | Tazeen Ahmad56% | → $33 | Initiates | → Buy | Get Alert |
08/12/2020 | FULC | Buy Now | Fulcrum Therapeutics | $6.85 | 60.58% | Tazeen Ahmad56% | → $11 | Downgrade | Neutral → Underperform | Get Alert |
08/10/2020 | PTCT | Buy Now | PTC Therapeutics | $51.26 | 13.15% | Tazeen Ahmad56% | $60 → $58 | Maintains | Buy | Get Alert |
08/03/2020 | IMMU | Buy Now | Immunomedics | — | — | Tazeen Ahmad56% | $45 → $47 | Maintains | Buy | Get Alert |
07/21/2020 | BNTX | Buy Now | BioNTech | $106.57 | -1.47% | Tazeen Ahmad56% | $71 → $105 | Upgrade | Neutral → Buy | Get Alert |
07/21/2020 | AKUS | Buy Now | Akouos | — | — | Tazeen Ahmad56% | → $24 | Initiates | → Buy | Get Alert |
06/19/2020 | FULC | Buy Now | Fulcrum Therapeutics | $6.85 | 235.77% | Tazeen Ahmad56% | $19 → $23 | Downgrade | Buy → Neutral | Get Alert |
06/10/2020 | SRPT | Buy Now | Sarepta Therapeutics | $36.36 | 395.05% | Tazeen Ahmad56% | $180 → $180 | Maintains | Buy | Get Alert |
04/28/2020 | BNTX | Buy Now | BioNTech | $106.57 | -52.14% | Tazeen Ahmad56% | $46 → $51 | Downgrade | Buy → Neutral | Get Alert |
04/09/2020 | CLVS | Buy Now | Clovis Oncology | — | — | Tazeen Ahmad56% | → $6 | Downgrade | Neutral → Underperform | Get Alert |
03/27/2020 | SRPT | Buy Now | Sarepta Therapeutics | $36.36 | 395.05% | Tazeen Ahmad56% | → $180 | Maintains | Buy | Get Alert |
02/26/2020 | GWPH | Buy Now | GW Pharmaceuticals | — | — | Tazeen Ahmad56% | $233 → $227 | Maintains | Buy | Get Alert |
02/10/2020 | ARGX | Buy Now | argenx | $577.89 | — | Tazeen Ahmad56% | — | Initiates | → Buy | Get Alert |
01/23/2020 | CLVS | Buy Now | Clovis Oncology | — | — | Tazeen Ahmad56% | $7 → $10 | Maintains | Neutral | Get Alert |
01/23/2020 | FULC | Buy Now | Fulcrum Therapeutics | $6.85 | 221.17% | Tazeen Ahmad56% | $19 → $22 | Maintains | Buy | Get Alert |
12/20/2019 | IMMU | Buy Now | Immunomedics | — | — | Tazeen Ahmad56% | → $26 | Initiates | → Buy | Get Alert |
12/19/2019 | APLS | Buy Now | Apellis Pharmaceuticals | $18.83 | 91.18% | Tazeen Ahmad56% | → $36 | Initiates | → Buy | Get Alert |
12/09/2019 | ETNB | Buy Now | 89bio | $10.40 | 217.31% | Tazeen Ahmad56% | → $33 | Initiates | → Neutral | Get Alert |
12/02/2019 | GRTX | Buy Now | Galera Therapeutics | $0.02 | 63459.32% | Tazeen Ahmad56% | → $15 | Initiates | → Buy | Get Alert |
11/15/2019 | BCRX | Buy Now | BioCryst Pharma | $10.25 | — | Tazeen Ahmad56% | — | Upgrade | Neutral → Buy | Get Alert |
11/04/2019 | BNTX | Buy Now | BioNTech | $106.57 | -80.29% | Tazeen Ahmad56% | → $21 | Initiates | → Buy | Get Alert |
09/30/2019 | ADMS | Buy Now | Adamas Pharmaceuticals | — | — | Tazeen Ahmad56% | — | Downgrade | Neutral → Underperform | Get Alert |
08/13/2019 | CLVS | Buy Now | Clovis Oncology | — | — | Tazeen Ahmad56% | $13 → $7 | Downgrade | Buy → Neutral | Get Alert |
08/12/2019 | FULC | Buy Now | Fulcrum Therapeutics | $6.85 | 177.37% | Tazeen Ahmad56% | → $19 | Initiates | → Buy | Get Alert |
05/13/2019 | PTCT | Buy Now | PTC Therapeutics | $51.26 | -4.41% | Tazeen Ahmad56% | $43 → $49 | Upgrade | Neutral → Buy | Get Alert |
04/25/2019 | PTC | Buy Now | PTC | $169.34 | — | Tazeen Ahmad56% | — | Downgrade | Neutral → Underperform | Get Alert |
11/02/2018 | DBVT | Buy Now | DBV Technologies | $9.30 | 222.58% | Tazeen Ahmad56% | $33 → $30 | Maintains | Buy | Get Alert |
11/02/2018 | TSRO | Buy Now | Tesaro | — | — | Tazeen Ahmad56% | $38 → $39 | Maintains | Neutral | Get Alert |
10/16/2018 | SPRO | Buy Now | Spero Therapeutics | $2.81 | 220.28% | Tazeen Ahmad56% | $19 → $9 | Downgrade | Neutral → Underperform | Get Alert |
10/10/2018 | PCRX | Buy Now | Pacira BioSciences | $24.06 | 99.5% | Tazeen Ahmad56% | $46 → $48 | Maintains | Neutral | Get Alert |
10/10/2018 | ACAD | Buy Now | ACADIA Pharmaceuticals | $21.71 | 15.15% | Tazeen Ahmad56% | $22 → $25 | Maintains | Buy | Get Alert |
10/05/2018 | ADMS | Buy Now | Adamas Pharmaceuticals | — | — | Tazeen Ahmad56% | $36 → $25 | Downgrade | Buy → Neutral | Get Alert |
09/11/2018 | RARE | Buy Now | Ultragenyx Pharmaceutical | $37.49 | 150.73% | Tazeen Ahmad56% | $72 → $94 | Maintains | Buy | Get Alert |
09/11/2018 | TSRO | Buy Now | Tesaro | — | — | Tazeen Ahmad56% | $35 → $38 | Maintains | Neutral | Get Alert |
08/06/2018 | TSRO | Buy Now | Tesaro | — | — | Tazeen Ahmad56% | — | Downgrade | Buy → Neutral | Get Alert |
08/06/2018 | PCRX | Buy Now | Pacira BioSciences | $24.06 | — | Tazeen Ahmad56% | — | Downgrade | Buy → Neutral | Get Alert |
07/31/2018 | PTCT | Buy Now | PTC Therapeutics | $51.26 | -39.52% | Tazeen Ahmad56% | $27 → $31 | Maintains | Underperform | Get Alert |
06/26/2018 | GWPH | Buy Now | GW Pharmaceuticals | — | — | Tazeen Ahmad56% | $170 → $200 | Maintains | Buy | Get Alert |
06/19/2018 | PTC | Buy Now | PTC | $169.34 | -39.77% | Tazeen Ahmad56% | $86 → $102 | Maintains | Neutral | Get Alert |
05/04/2018 | TSRO | Buy Now | Tesaro | — | — | Tazeen Ahmad56% | $94 → $88 | Maintains | Buy | Get Alert |
05/01/2018 | NBIX | Buy Now | Neurocrine Biosciences | $124.39 | -18% | Tazeen Ahmad56% | $101 → $102 | Maintains | Buy | Get Alert |
03/27/2018 | ADMS | Buy Now | Adamas Pharmaceuticals | — | — | Tazeen Ahmad56% | → $39 | Initiates | → Buy | Get Alert |
02/21/2018 | RARE | Buy Now | Ultragenyx Pharmaceutical | $37.49 | 62.71% | Tazeen Ahmad56% | $60 → $61 | Maintains | Buy | Get Alert |
02/07/2018 | SGEN | Buy Now | Seagen | — | — | Tazeen Ahmad56% | $70 → $68 | Maintains | Neutral | Get Alert |
02/06/2018 | GWPH | Buy Now | GW Pharmaceuticals | — | — | Tazeen Ahmad56% | $154 → $149 | Maintains | Buy | Get Alert |
01/25/2018 | ASND | Buy Now | Ascendis Pharma | $170.80 | -64.87% | Tazeen Ahmad56% | $45 → $60 | Maintains | Buy | Get Alert |
01/18/2018 | PTC | Buy Now | PTC | $169.34 | — | Tazeen Ahmad56% | — | Upgrade | Underperform → Neutral | Get Alert |
11/27/2017 | SPRO | Buy Now | Spero Therapeutics | $2.81 | 469.4% | Tazeen Ahmad56% | → $16 | Initiates | → Neutral | Get Alert |
11/17/2017 | ASND | Buy Now | Ascendis Pharma | $170.80 | -74.82% | Tazeen Ahmad56% | $46 → $43 | Maintains | Buy | Get Alert |
11/16/2017 | SAGE | Buy Now | Sage Therapeutics | $6.90 | 1363.79% | Tazeen Ahmad56% | $103 → $101 | Maintains | Buy | Get Alert |
11/14/2017 | GWPH | Buy Now | GW Pharmaceuticals | — | — | Tazeen Ahmad56% | $160 → $158 | Maintains | Buy | Get Alert |
11/10/2017 | AVXS | Buy Now | AveXis | — | — | Tazeen Ahmad56% | $115 → $112 | Maintains | Buy | Get Alert |
11/06/2017 | PTC | Buy Now | PTC | $169.34 | -64.57% | Tazeen Ahmad56% | → $60 | Initiates | → Underperform | Get Alert |
10/30/2017 | RYTM | Buy Now | Rhythm Pharmaceuticals | $62.90 | -52.31% | Tazeen Ahmad56% | → $30 | Initiates | → Buy | Get Alert |
10/27/2017 | SGEN | Buy Now | Seagen | — | — | Tazeen Ahmad56% | — | Upgrade | Underperform → Neutral | Get Alert |
10/26/2017 | PTCT | Buy Now | PTC Therapeutics | $51.26 | — | Tazeen Ahmad56% | — | Downgrade | Neutral → Underperform | Get Alert |
10/04/2017 | PCRX | Buy Now | Pacira BioSciences | $24.06 | 87.03% | Tazeen Ahmad56% | $46 → $45 | Maintains | Buy | Get Alert |
05/05/2017 | NBIX | Buy Now | Neurocrine Biosciences | $124.39 | -43.73% | Tazeen Ahmad56% | → $70 | Initiates | → Buy | Get Alert |
02/10/2017 | SGEN | Buy Now | Seagen | — | — | Tazeen Ahmad56% | — | Downgrade | Neutral → Underperform | Get Alert |
01/27/2017 | CLVS | Buy Now | Clovis Oncology | — | — | Tazeen Ahmad56% | — | Initiates | → Buy | Get Alert |
11/08/2016 | ACAD | Buy Now | ACADIA Pharmaceuticals | $21.71 | — | Tazeen Ahmad56% | — | Upgrade | Neutral → Buy | Get Alert |
10/21/2016 | AVXS | Buy Now | AveXis, Inc. - Common Stock | — | — | Tazeen Ahmad56% | — | Initiates | → Buy | Get Alert |
10/10/2016 | TSRO | Buy Now | TESARO, Inc. - Common Stock | — | — | Tazeen Ahmad56% | — | Upgrade | Neutral → Buy | Get Alert |
08/30/2016 | TSRO | Buy Now | Tesaro | — | — | Tazeen Ahmad56% | — | Initiates | → Neutral | Get Alert |
06/28/2016 | RARE | Buy Now | Ultragenyx Pharmaceutical | $37.49 | — | Tazeen Ahmad56% | — | Initiates | → Buy | Get Alert |
06/22/2016 | ACAD | Buy Now | ACADIA Pharmaceuticals | $21.71 | — | Tazeen Ahmad56% | — | Downgrade | Buy → Neutral | Get Alert |
02/29/2016 | PTCT | Buy Now | PTC Therapeutics | $51.26 | — | Tazeen Ahmad56% | — | Downgrade | Buy → Neutral | Get Alert |
02/08/2016 | ACAD | Buy Now | ACADIA Pharmaceuticals | $21.71 | 84.25% | Tazeen Ahmad56% | → $40 | Initiates | → Buy | Get Alert |
11/11/2015 | BCRX | Buy Now | BioCryst Pharma | $10.25 | — | Tazeen Ahmad56% | — | Downgrade | Neutral → Underperform | Get Alert |
07/31/2015 | PCRX | Buy Now | Pacira BioSciences | $24.06 | — | Tazeen Ahmad56% | — | Upgrade | Underperform → Neutral | Get Alert |
06/30/2015 | BCRX | Buy Now | BioCryst Pharma | $10.25 | 85.37% | Tazeen Ahmad56% | $12 → $19 | Upgrade | Neutral → Buy | Get Alert |
04/20/2015 | BCRX | Buy Now | BioCryst Pharma | $10.25 | — | Tazeen Ahmad56% | — | Upgrade | Underperform → Neutral | Get Alert |
02/26/2015 | PCRX | Buy Now | Pacira BioSciences | $24.06 | — | Tazeen Ahmad56% | — | Downgrade | Neutral → Underperform | Get Alert |
02/23/2015 | ASND | Buy Now | Ascendis Pharma | $170.80 | — | Tazeen Ahmad56% | — | Initiates | → Buy | Get Alert |
12/04/2014 | BCRX | Buy Now | BioCryst Pharma | $10.25 | -21.95% | Tazeen Ahmad56% | $9 → $8 | Maintains | Underperform | Get Alert |
10/31/2014 | PCRX | Buy Now | Pacira BioSciences | $24.06 | — | Tazeen Ahmad56% | — | Downgrade | Buy → Neutral | Get Alert |
10/13/2014 | PTCT | Buy Now | PTC Therapeutics | $51.26 | -6.36% | Tazeen Ahmad56% | $50 → $48 | Maintains | Buy | Get Alert |
09/30/2014 | SGEN | Buy Now | Seagen | — | — | Tazeen Ahmad56% | — | Downgrade | → Underperform | Get Alert |
09/23/2014 | PTCT | Buy Now | PTC Therapeutics | $51.26 | -2.46% | Tazeen Ahmad56% | $37 → $50 | Maintains | Buy | Get Alert |
05/06/2014 | SGEN | Buy Now | Seagen | — | — | Tazeen Ahmad56% | $46 → $40 | Upgrade | Underperform → Neutral | Get Alert |
03/11/2014 | GWPH | Buy Now | GW Pharmaceuticals | — | — | Tazeen Ahmad56% | → $93 | Initiates | → Buy | Get Alert |
02/24/2014 | SGEN | Buy Now | Seagen | — | — | Tazeen Ahmad56% | → $46 | Assumes | → Underperform | Get Alert |
01/28/2014 | BCRX | Buy Now | BioCryst Pharma | $10.25 | — | Tazeen Ahmad56% | — | Downgrade | Neutral → Underperform | Get Alert |
11/12/2013 | BCRX | Buy Now | BioCryst Pharma | $10.25 | — | Tazeen Ahmad56% | — | Upgrade | Underperform → Neutral | Get Alert |
07/31/2013 | BCRX | Buy Now | BioCryst Pharma | $10.25 | -70.73% | Tazeen Ahmad56% | $2 → $3 | Downgrade | Neutral → Underperform | Get Alert |
02/04/2013 | BCRX | Buy Now | BioCryst Pharma | $10.25 | -80.49% | Tazeen Ahmad56% | → $2 | Assumes | → Neutral | Get Alert |